Implementation of risk enhancers in ASCVD risk estimation and hypolipidemic treatment eligibility: A sex-specific analysis.
Georgiopoulos G, Delialis D, Aivalioti E, Georgakis V, Mavraganis G, Angelidakis L, Bampatsias D, Armeni E, Maneta E, Patras R, Dimopoulou MA, Oikonomou E, Kanakakis I, Lambrinoudaki I, Lagiou A, Xenos P, Stamatelopoulos K.
Georgiopoulos G, et al. Among authors: lagiou a.
Hellenic J Cardiol. 2023 Sep-Oct;73:16-23. doi: 10.1016/j.hjc.2023.02.006. Epub 2023 Feb 17.
Hellenic J Cardiol. 2023.
PMID: 36805072
Free article.